The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10 years
机构:[1]Central Lab, Liver Disease Research Center, The Second People’s Hospital of Yunnan Province, Kunming, Yunnan Province, China[2]The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China昆明医科大学附属第一医院[3]Clinical Lab, The Third People’s Hospital of Kunming City, Kunming, Yunnan Province, China[4]Hepatopancreatobiliary Surgery Department, The Second People’s Hospital of Yunnan Province, Kunming, Yunnan Province, China
We are grateful to all of the participants for their willingness to participate in this study. This work was supported by grants from the Yunnan Natural Science Foundation ( 202001AT070085 , China), Health Research Institution Project of Yunnan Province ( 2018NS0003 , China), Major Science and Technology Special Project of Yunnan Province (Biomedicine) ( 202003AC100010 , China), High-level Health Technical Personnel Project of Yunnan Province ( H-2018102 , China), Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Fund ( 2019FE001(-195) , China), and National Natural Science Foundation of China ( 81960116; 82060368 , China).
第一作者机构:[1]Central Lab, Liver Disease Research Center, The Second People’s Hospital of Yunnan Province, Kunming, Yunnan Province, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Zhou T.-C,Liu F.-W,Fan J.-H,et al.The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10 years[J].INFECTION GENETICS AND EVOLUTION.2021,89:doi:10.1016/j.meegid.2021.104706.
APA:
Zhou, T.-C,Liu, F.-W,Fan, J.-H,Zhang, S.-H,Lv, S.-Q...&Wei, J.(2021).The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10 years.INFECTION GENETICS AND EVOLUTION,89,
MLA:
Zhou, T.-C,et al."The association of the heterogeneity of HBV reverse transcriptase quasispecies with antiviral efficacy after treatment with nucleos(t)ide analogues for 10 years".INFECTION GENETICS AND EVOLUTION 89.(2021)